TSX: ACB
EDMONTON, Jan. 8, 2018
/CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (TSX: ACB)
(OTCQB: ACBFF) (Frankfurt: 21P;
WKN: A1C4WM) is pleased to announce that Cam Battley has been promoted to Chief Corporate
Officer (CCO).
Mr. Battley joined the Company in March, 2016, and previously
held the positions of Executive Vice President and Senior Vice
President with Aurora. In his new role, he will be the lead
external-facing executive of the Company, responsible for
establishing and managing relationships with shareholders, industry
analysts, news media, securities regulators, licensing bodies,
governments, other companies and organizations operating in the
cannabis sector, and other external stakeholders. He will also
chair the Executive Committee, work closely with the Company's
legal counsel, act as liaison with the Board of Directors, and
ensure organizational alignment with regard to strategic
partnerships and corporate development across all of the Company's
operations, domestic and international.
Mr. Battley, who has more than 15 years of experience in the
global biopharmaceutical industry, is a member of the Board of
Directors of Cannabis Canada, the trade association for Health
Canada Licensed Producers. He also currently serves as a member of
the Board of the patient advocacy group Campaigning for Cancer
(South Africa), and of Micron
Waste Technologies Inc. (CSE: MWM), a Vancouver-based developer of advanced
digesters for organic waste materials.
"Cam's experience, judgment, energy, and passion for this
business have been key drivers in Aurora's rapid emergence as a
leader in the global cannabis industry," said Terry Booth, CEO. "I am extremely proud of the
quality, competence and consistent execution of our executive team,
and am delighted that Cam will be playing a central role with
Aurora as we accelerate our domestic and international
expansion."
About Aurora
Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises
Inc., is a licensed producer of medical cannabis pursuant to Health
Canada's Access to Cannabis for Medical Purposes Regulations
("ACMPR"). The Company operates a 55,200 square foot,
state-of-the-art production facility in Mountain View County,
Alberta, known as "Aurora
Mountain", a second 40,000 square foot high-technology production
facility known as "Aurora Vie" in Pointe-Claire, Quebec on Montreal's West Island, and is currently
constructing an 800,000 square foot production facility, known as
"Aurora Sky", at the Edmonton
International Airport, as well as is completing a fourth facility
in Lachute, Quebec through its
wholly owned subsidiary Aurora Larssen Projects Ltd.
In addition, the Company holds approximately 17.23% of the
issued shares in leading extraction technology company Radient
Technologies Inc., based in Edmonton, and is in the process of completing
an investment in Edmonton-based
Hempco Food and Fiber for an ownership stake of up to 50.1%.
Furthermore, Aurora is the cornerstone investor with a 22.9% stake
in Cann Group Limited, the first Australian company licensed to
conduct research on and cultivate medical cannabis. Aurora also
owns Pedanios, a leading wholesale importer, exporter, and
distributor of medical cannabis in the European Union, based in
Germany. The Company offers
further differentiation through its acquisition of BC Northern
Lights Ltd. and Urban Cultivator Inc., industry leaders,
respectively, in the production and sale of proprietary systems for
the safe, efficient and high-yield indoor cultivation of cannabis,
and in state-of-the-art indoor gardening appliances for the
cultivation of organic microgreens, vegetables and herbs in home
and professional kitchens. Aurora's common shares trade on the TSX
under the symbol "ACB".
On behalf of the Boards of
Directors,
AURORA CANNABIS
INC.
Terry
Booth
CEO
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. These statements are only predictions.
Various assumptions were used in drawing the conclusions or making
the projections contained in the forward-looking statements
throughout this news release. Forward-looking statements are based
on the opinions and estimates of management at the date the
statements are made, and are subject to a variety of risks and
uncertainties and other factors that could cause actual events or
results to differ materially from those projected in the
forward-looking statements. The Company is under no obligation, and
expressly disclaims any intention or obligation, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as expressly
required by applicable law.
Neither TSX nor its Regulation Services Provider (as that
term is defined in the policies of Toronto Stock Exchange) accepts
responsibility for the adequacy or accuracy of this
release.
SOURCE Aurora Cannabis Inc.